About Genees Pharmaceutical
Genees Pharmaceutical is a Healthcare company. Dermatology products manufacturing and supply in India. The company has 47 employees. Its Indian entity Genees Pharmaceutical Private Limited reported revenue of ₹13.26 Cr. Genees Pharmaceutical offers products and services including Dermorize and Pigmocare. Its focus areas include Pharmaceuticals, Dermatology, Skin Care Products and General Pharma.
Company details
Genees Pharmaceutical is identified as a company established in 2012, focusing on dermatology and providing innovative skin care products that are scientifically proven for quality and efficacy. It is recognized for offering affordable healthcare solutions in the pharma formulations sector, with a commitment to meeting consumer needs through wholesale and retail channels. The companys endeavors in drug discovery are noted for their role in therapeutic areas, aiming to extend global healing solutions while adhering to high standards of conduct.
- Employees 47
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Social LinkedIn X Facebook Instagram
- Legal Name Genees Pharmaceutical Pvt. Ltd
- Date of Incorporation 10 Aug, 2012
- Jurisdiction Pune, Maharashtra, India
- Indian entity revenue₹13.26 Cr
FY 2025 · +27% YoY
- Indian entity net profit₹82 Lakh
FY 2025 · 6% margin
- Indian entity EBITDA₹1.15 Cr
FY 2025 · 9% margin
- Employee Count47
Associated legal entities of Genees Pharmaceutical
Genees Pharmaceutical operates through Genees Pharmaceutical Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Genees Pharmaceutical Private Limited CIN U24234PN2012PTC144352 | Active | 10 Aug 2012 | Pune, Maharashtra | ₹13.3 Cr | 47 | 5 | View details |
Products & Services of Genees Pharmaceutical
Genees Pharmaceutical offers a comprehensive portfolio of products and services, including Dermorize and Pigmocare.
This product is utilized for dermatology purposes and is made available as part of the company's offerings
This product is provided for addressing pigmentation issues within the dermatology segment
Board of directors of Genees Pharmaceutical Private Limited (Genees Pharmaceutical)
Genees Pharmaceutical Private Limited is the primary company behind Genees Pharmaceutical. The board of Genees Pharmaceutical Private Limited currently have 5 directors; the longest-serving is Sagar Krishna Gurav, appointed in 2019. 9 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sagar Krishna Gurav DIN 08477978 | Director | 11 Jun 2019 | 7 yrs 4 mo | Genees Pharmaceutical Private Limited |
| Vishal Vinod Kagdelwar DIN 08529514 | Director | 05 Aug 2019 | 7 yrs 2 mo | Genees Pharmaceutical Private Limited |
| Vishwas Bajirao Bajare DIN 08529520 | Director | 05 Aug 2019 | 7 yrs 2 mo | Genees Pharmaceutical Private Limited |
| Ravindra Bhausaheb Zare DIN 08529459 | Director | 05 Aug 2019 | 7 yrs 2 mo | Genees Pharmaceutical Private Limited |
| Sameer Vasant Waghmare DIN 08529441 | Director | 05 Aug 2019 | 7 yrs 2 mo | Genees Pharmaceutical Private Limited |
Financials of Genees Pharmaceutical
Figures of Genees Pharmaceutical Private Limited, the primary company behind Genees Pharmaceutical, for FY 2025. Revenue was ₹13.26 Cr (+27% year on year). Net profit was ₹82 Lakh (6% margin). EBITDA was ₹1.15 Cr (9% margin). Revenue has grown at a compounded annual rate of +34% over three years and +55% over five years.
- ₹13.26 CrRevenue · FY 2025 · +27% YoY
- ₹82 LakhNet profit · 6% margin
- ₹1.15 CrEBITDA · 9% margin
- ₹29.5 LakhPaid-up capital
- 47Employees (provident fund records)
- +34%Revenue CAGR, 3 years
- +55%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Genees Pharmaceutical Private Limited are on its company page.
Detailed financial statements for Genees Pharmaceutical
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Genees Pharmaceutical
Genees Pharmaceutical has 47 employees.
The primary company behind Genees Pharmaceutical, Genees Pharmaceutical Private Limited, reported revenue of ₹13.26 Cr for FY 2025, up 27% year on year.
Genees Pharmaceutical is identified as a company established in 2012, focusing on dermatology and providing innovative skin care products that are scientifically proven for quality and efficacy. It is recognized for offering affordable healthcare solutions in the pharma formulations sector, with a commitment to meeting consumer needs through wholesale and retail channels. The companys endeavors in drug discovery are noted for their role in therapeutic areas, aiming to extend global healing solutions while adhering to high standards of conduct.
Genees Pharmaceutical offers Dermorize and Pigmocare.
Genees Pharmaceutical operates through Genees Pharmaceutical Private Limited.
The legal entities of Genees Pharmaceutical currently have 5 directors, including Vishal Vinod Kagdelwar, Vishwas Bajirao Bajare, Ravindra Bhausaheb Zare and others.